Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target.
Share this article
Corporate
Score 65
Bullish
Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target
Mar 18, 2026 14:13 UTC
IONS
Medium term
Related Articles
Score 72
Bullish
FDA Approves Johnson & Johnson's Oral Psoriasis Pill, Challenging Top Injectables
Mar 18, 17:17
Score 65
Bullish
Century Lithium feasibility study update boosts angel Island project economics, Noble Capital says
Mar 18, 17:15
Score 35
This Staffing Stock Has Plunged 56% in a Year, but Does a Nearly $10 Million Buy Signal a Turnaround Looming?
Mar 18, 17:09
Score 85
Bullish
Lumentum Raises Revenue Forecast, Bolstering AI Hardware Momentum
Mar 18, 17:01
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.